|
1
|
Brown JM and Giaccia AJ: The unique
physiology of solid tumors: Opportunities (and problems) for cancer
therapy. Cancer Res. 58:1408–1416. 1998.PubMed/NCBI
|
|
2
|
Daşu A, Toma-Daşu I and Karlsson M:
Theoretical simulation of tumour oxygenation and results from acute
and chronic hypoxia. Phys Med Biol. 48:2829–2842. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi SW and Mason JB: Folate status:
Effects on pathways of colorectal carcinogenesis. J Nutr.
132:(Suppl). 2413S–2418S. 2002.PubMed/NCBI
|
|
5
|
Duthie SJ and Hawdon A: DNA instability
(strand breakage, uracil misincorporation, and defective repair) is
increased by folic acid depletion in human lymphocytes in vitro.
FASEB J. 12:1491–1497. 1998.PubMed/NCBI
|
|
6
|
Widschwendter M and Jones PA: DNA
methylation and breast carcinogenesis. Oncogene. 21:5462–5482.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pike ST, Rajendra R, Artzt K and Appling
DR: Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports
the flow of mitochondrial one-carbon units into the methyl cycle in
embryos. J Biol Chem. 285:4612–4620. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ventrella-Lucente LF, Unnikrishnan A,
Pilling AB, Patel HV, Kushwaha D, Dombkowski AA, Schmelz EM,
Cabelof DC and Heydari AR: Folate deficiency provides protection
against colon carcinogenesis in DNA polymerase beta
haploinsufficient mice. J Biol Chem. 285:19246–19258. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jain M, Nilsson R, Sharma S, Madhusudhan
N, Kitami T, Souza AL, Kafri R, Kirschner MW, Clish CB and Mootha
VK: Metabolite profiling identifies a key role for glycine in rapid
cancer cell proliferation. Science. 336:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vazquez A, Tedeschi PM and Bertino JR:
Overexpression of the mitochondrial folate and glycine-serine
pathway: A new determinant of methotrexate selectivity in tumors.
Cancer Res. 73:478–482. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu F, Liu Y, He C, Tao L, He X, Song H
and Zhang G: Increased MTHFD2 expression is associated with poor
prognosis in breast cancer. Tumour Biol. 35:8685–8690. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Díez-Villanueva A, Mallona I and Peinado
MA: Wanderer, an interactive viewer to explore DNA methylation and
gene expression data in human cancer. Epigenetics Chromatin.
8:222015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koseki J, Colvin H, Fukusumi T, Nishida N,
Konno M, Kawamoto K, Tsunekuni K, Matsui H, Doki Y, Mori M, et al:
Mathematical analysis predicts imbalanced IDH1/2 expression
associates with 2-HG-inactivating β-oxygenation pathway in
colorectal cancer. Int J Oncol. 46:1181–1191. 2015.PubMed/NCBI
|
|
16
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Handbook: From the AJCC
Cancer Staging Manual. Springer; New York: 2011
|
|
17
|
Miyo M, Yamamoto H, Konno M, Colvin H,
Nishida N, Koseki J, Kawamoto K, Ogawa H, Hamabe A, Uemura M, et
al: Tumour-suppressive function of SIRT4 in human colorectal
cancer. Br J Cancer. 113:492–499. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nilsson R, Jain M, Madhusudhan N, Sheppard
NG, Strittmatter L, Kampf C, Huang J, Asplund A and Mootha VK:
Metabolic enzyme expression highlights a key role for MTHFD2 and
the mitochondrial folate pathway in cancer. Nat Commun. 5:31282014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dang L, White DW, Gross S, Bennett BD,
Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et
al: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.
Nature. 462:739–744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin S, Chen J, Chen L, Histen G, Lin Z,
Gross S, Hixon J, Chen Y, Kung C, Chen Y, et al: ALDH2(E487K)
mutation increases protein turnover and promotes murine
hepatocarcinogenesis. Proc Natl Acad Sci USA. 112:9088–9093. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lehtinen L, Ketola K, Mäkelä R, Mpindi JP,
Viitala M, Kallioniemi O and Iljin K: High-throughput RNAi
screening for novel modulators of vimentin expression identifies
MTHFD2 as a regulator of breast cancer cell migration and invasion.
Oncotarget. 4:48–63. 2013.PubMed/NCBI
|
|
22
|
Kim D, Fiske BP, Birsoy K, Freinkman E,
Kami K, Possemato RL, Chudnovsky Y, Pacold ME, Chen WW, Cantor JR,
et al: SHMT2 drives glioma cell survival in ischaemia but imposes a
dependence on glycine clearance. Nature. 520:363–367. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ben-Sahra I, Hoxhaj G, Ricoult SJ, Asara
JM and Manning BD: mTORC1 induces purine synthesis through control
of the mitochondrial tetrahydrofolate cycle. Science. 351:728–733.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Csibi A, Fendt SM, Li C, Poulogiannis G,
Choo AY, Chapski DJ, Jeong SM, Dempsey JM, Parkhitko A, Morrison T,
et al: The mTORC1 pathway stimulates glutamine metabolism and cell
proliferation by repressing SIRT4. Cell. 153:840–854. 2013.
View Article : Google Scholar : PubMed/NCBI
|
